You have no items in your shopping cart.
All Products
Recombinant Human PCSK9 (D374Y,C-6His) [orb2993449]Predicted: 15-18&60-80 KDa. Observed: 13.8&58.2 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Macaca nemestrina PCSK9 (C-6His) [orb2993450]
Predicted: 14&59 KDa. Observed: 16-21&55-77 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse PCSK9 (C-6His) [orb2993451]
Predicted: 14&58.2 KDa. Observed: 19&60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human PCSK9 (C-8His-HA-Avi) [orb2993452]
Predicted: 14&62 KDa. Observed: 18&58-70&90-150 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human PCSK9 (C-Avi) [orb2993453]
Predicted: 14&59 KDa. Observed: 19&65 KDa, reducing conditions
100 μg, 20 μg - Recombinant Human PCSK9 (C-6His) [orb2993454]
Predicted: 13.77&58.2 KDa. Observed: 19&60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human HYAL1 (C-6His) [orb2993455]
Predicted: 47.18 KDa. Observed: 50-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PDIA4 (C-6His) [orb2993456]
Predicted: 71.7 KDa. Observed: 75 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PLRP2 (C-6His) [orb2993457]
Predicted: 51.16 KDa. Observed: 62 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PTGDS (C-6His) [orb2993458]
Predicted: 19.7 KDa. Observed: 20-27 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg